A new gel-based therapy is offering hope for glioblastoma treatment by combining anticancer drugs and antibodies—two therapies that are typically difficult to administer together. This innovative gel not only fights the cancer but also helps reprogram the immune system to prevent recurrence. In mouse models, researchers observed an unprecedented 100% survival rate, sparking excitement about its potential impact on glioblastoma patients.
